PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of “Hold” by Analysts
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has been assigned a consensus recommendation of “Hold” from the sixteen analysts that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has given […]
More Stories
FY2026 Earnings Estimate for WaFd Issued By DA Davidson
WaFd, Inc (NASDAQ:WAFD – Free Report) – Stock analysts at DA Davidson issued their FY2026 EPS estimates for shares of...
Q1 Earnings Forecast for SentinelOne Issued By KeyCorp
SentinelOne, Inc. (NYSE:S – Free Report) – Research analysts at KeyCorp issued their Q1 2026 earnings estimates for shares of...
Research Analysts Set Expectations for CMC FY2027 Earnings
Commercial Metals (NYSE:CMC – Free Report) – Analysts at Zacks Research lowered their FY2027 earnings per share estimates for Commercial...
Zacks Research Issues Pessimistic Outlook for ERIC Earnings
Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC – Free Report) – Equities researchers at Zacks Research decreased their Q4 2025 earnings per...
B. Riley Has Optimistic Outlook of CVE:HIV FY2025 Earnings
HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Analysts at B. Riley raised their FY2025 earnings estimates for HIVE...
Autozi Internet Technology (Global) (NASDAQ:AZI) versus Driven Brands (NASDAQ:DRVN) Head to Head Comparison
Driven Brands (NASDAQ:DRVN – Get Free Report) and Autozi Internet Technology (Global) (NASDAQ:AZI – Get Free Report) are both retail/wholesale...